 Nathan Novotny
Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 12 | 2025 | 481 | 4.990 |
Why?
| | Robotic Surgical Procedures | 5 | 2025 | 185 | 1.990 |
Why?
| | Appendicitis | 6 | 2026 | 150 | 1.890 |
Why?
| | Herniorrhaphy | 6 | 2025 | 76 | 1.750 |
Why?
| | Appendectomy | 5 | 2020 | 90 | 1.610 |
Why?
| | Hernia, Inguinal | 4 | 2023 | 43 | 1.590 |
Why?
| | Simulation Training | 5 | 2026 | 135 | 1.550 |
Why?
| | Pyloric Stenosis, Hypertrophic | 3 | 2024 | 10 | 1.440 |
Why?
| | Pyloromyotomy | 2 | 2024 | 3 | 1.360 |
Why?
| | General Surgery | 4 | 2026 | 206 | 1.300 |
Why?
| | Foreign Bodies | 4 | 2022 | 110 | 1.290 |
Why?
| | Clinical Competence | 6 | 2026 | 1243 | 1.170 |
Why?
| | Disposable Equipment | 2 | 2020 | 24 | 1.150 |
Why?
| | Surgical Instruments | 2 | 2020 | 51 | 1.130 |
Why?
| | Retrospective Studies | 33 | 2026 | 17291 | 0.980 |
Why?
| | Pediatric Nursing | 1 | 2026 | 44 | 0.940 |
Why?
| | Chest Tubes | 1 | 2026 | 34 | 0.940 |
Why?
| | Duodenal Obstruction | 1 | 2025 | 6 | 0.910 |
Why?
| | Surgical Stapling | 1 | 2025 | 15 | 0.900 |
Why?
| | Formative Feedback | 1 | 2026 | 36 | 0.900 |
Why?
| | Anastomosis, Surgical | 2 | 2025 | 162 | 0.900 |
Why?
| | Wounds, Nonpenetrating | 3 | 2023 | 321 | 0.880 |
Why?
| | Duodenum | 1 | 2025 | 77 | 0.870 |
Why?
| | Magnets | 3 | 2022 | 21 | 0.870 |
Why?
| | Feedback | 1 | 2026 | 180 | 0.870 |
Why?
| | Colectomy | 1 | 2025 | 106 | 0.860 |
Why?
| | Abdominal Injuries | 2 | 2023 | 130 | 0.850 |
Why?
| | Suture Techniques | 1 | 2025 | 137 | 0.840 |
Why?
| | Hernia, Femoral | 1 | 2024 | 4 | 0.830 |
Why?
| | Needs Assessment | 2 | 2026 | 402 | 0.800 |
Why?
| | Tracheoesophageal Fistula | 2 | 2022 | 40 | 0.780 |
Why?
| | Child | 32 | 2026 | 22707 | 0.760 |
Why?
| | Internship and Residency | 5 | 2026 | 1267 | 0.750 |
Why?
| | Peritoneum | 2 | 2023 | 43 | 0.700 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2022 | 70 | 0.690 |
Why?
| | Colitis, Ulcerative | 1 | 2023 | 148 | 0.670 |
Why?
| | Gastroschisis | 1 | 2021 | 33 | 0.660 |
Why?
| | Digestive System Surgical Procedures | 1 | 2022 | 112 | 0.660 |
Why?
| | Rural Population | 1 | 2025 | 659 | 0.630 |
Why?
| | Humans | 68 | 2026 | 145475 | 0.630 |
Why?
| | Bronchoscopy | 2 | 2018 | 227 | 0.620 |
Why?
| | Operative Time | 4 | 2025 | 181 | 0.610 |
Why?
| | Thoracoscopy | 1 | 2020 | 60 | 0.610 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 64 | 0.610 |
Why?
| | Bronchi | 2 | 2018 | 263 | 0.600 |
Why?
| | Biological Products | 1 | 2023 | 257 | 0.590 |
Why?
| | Caustics | 1 | 2019 | 6 | 0.590 |
Why?
| | Accidents, Home | 1 | 2019 | 33 | 0.580 |
Why?
| | Esophageal Diseases | 1 | 2019 | 30 | 0.580 |
Why?
| | Burns, Chemical | 1 | 2019 | 33 | 0.570 |
Why?
| | Adjuvants, Anesthesia | 1 | 2018 | 13 | 0.570 |
Why?
| | Postoperative Complications | 6 | 2026 | 2970 | 0.570 |
Why?
| | Patient Satisfaction | 2 | 2020 | 709 | 0.560 |
Why?
| | Developing Countries | 4 | 2024 | 316 | 0.560 |
Why?
| | Female | 41 | 2026 | 78845 | 0.560 |
Why?
| | Midazolam | 1 | 2018 | 73 | 0.550 |
Why?
| | Postoperative Care | 1 | 2020 | 286 | 0.530 |
Why?
| | Needles | 1 | 2018 | 63 | 0.530 |
Why?
| | Tracheal Neoplasms | 1 | 2017 | 12 | 0.530 |
Why?
| | Neurilemmoma | 1 | 2017 | 25 | 0.530 |
Why?
| | Child, Preschool | 16 | 2025 | 11853 | 0.520 |
Why?
| | Infant | 13 | 2025 | 10077 | 0.520 |
Why?
| | Metals, Rare Earth | 1 | 2017 | 3 | 0.520 |
Why?
| | Gastrostomy | 2 | 2009 | 130 | 0.510 |
Why?
| | Cautery | 1 | 2017 | 4 | 0.510 |
Why?
| | Inguinal Canal | 1 | 2017 | 11 | 0.510 |
Why?
| | Quality Improvement | 1 | 2026 | 1295 | 0.510 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 271 | 0.510 |
Why?
| | Male | 35 | 2026 | 72843 | 0.500 |
Why?
| | Rare Diseases | 1 | 2017 | 116 | 0.500 |
Why?
| | Esophagus | 1 | 2019 | 262 | 0.490 |
Why?
| | Abdomen | 2 | 2023 | 142 | 0.460 |
Why?
| | Global Health | 1 | 2019 | 403 | 0.460 |
Why?
| | Trachea | 1 | 2017 | 258 | 0.460 |
Why?
| | Treatment Outcome | 13 | 2026 | 11772 | 0.440 |
Why?
| | Anesthesia | 1 | 2018 | 256 | 0.430 |
Why?
| | Catheters, Indwelling | 2 | 2011 | 96 | 0.390 |
Why?
| | Patient-Centered Care | 1 | 2018 | 547 | 0.390 |
Why?
| | Recurrence | 5 | 2026 | 1138 | 0.390 |
Why?
| | Length of Stay | 6 | 2026 | 1349 | 0.380 |
Why?
| | Stem Cell Transplantation | 3 | 2008 | 189 | 0.380 |
Why?
| | Adolescent | 16 | 2026 | 22530 | 0.370 |
Why?
| | Sepsis | 2 | 2009 | 664 | 0.360 |
Why?
| | Robotics | 2 | 2023 | 90 | 0.350 |
Why?
| | Omentum | 1 | 2011 | 9 | 0.340 |
Why?
| | Neutropenia | 1 | 2011 | 154 | 0.320 |
Why?
| | Michigan | 3 | 2025 | 134 | 0.320 |
Why?
| | Rectus Abdominis | 1 | 2009 | 16 | 0.300 |
Why?
| | Peritoneal Dialysis | 1 | 2011 | 100 | 0.300 |
Why?
| | Angiopoietin-1 | 1 | 2009 | 12 | 0.290 |
Why?
| | Longevity | 1 | 2011 | 178 | 0.290 |
Why?
| | Infant, Newborn | 6 | 2025 | 6447 | 0.290 |
Why?
| | Compartment Syndromes | 1 | 2009 | 36 | 0.290 |
Why?
| | Fissure in Ano | 1 | 2008 | 4 | 0.290 |
Why?
| | Barium Radioisotopes | 1 | 2008 | 2 | 0.290 |
Why?
| | Estrogens | 2 | 2008 | 367 | 0.290 |
Why?
| | Barium | 1 | 2008 | 27 | 0.280 |
Why?
| | Fundoplication | 1 | 2009 | 52 | 0.280 |
Why?
| | Peptic Ulcer | 1 | 2008 | 18 | 0.280 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2008 | 78 | 0.280 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 252 | 0.260 |
Why?
| | Intestinal Volvulus | 1 | 2007 | 23 | 0.260 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 167 | 0.250 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2009 | 552 | 0.250 |
Why?
| | Practice Patterns, Physicians' | 2 | 2026 | 1371 | 0.240 |
Why?
| | Pilonidal Sinus | 1 | 2026 | 4 | 0.240 |
Why?
| | Neuroblastoma | 1 | 2008 | 174 | 0.240 |
Why?
| | Injury Severity Score | 3 | 2023 | 599 | 0.240 |
Why?
| | Gastroesophageal Reflux | 1 | 2009 | 237 | 0.240 |
Why?
| | Gastric Bypass | 1 | 2007 | 126 | 0.230 |
Why?
| | Duodenostomy | 1 | 2025 | 3 | 0.230 |
Why?
| | Ischemia | 1 | 2009 | 422 | 0.230 |
Why?
| | Intestinal Atresia | 1 | 2025 | 17 | 0.230 |
Why?
| | Adult | 12 | 2026 | 40777 | 0.230 |
Why?
| | Resuscitation Orders | 1 | 2025 | 48 | 0.220 |
Why?
| | Personal Autonomy | 1 | 2025 | 59 | 0.220 |
Why?
| | Analgesia | 1 | 2026 | 106 | 0.220 |
Why?
| | Interleukin-6 | 2 | 2008 | 776 | 0.220 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 611 | 0.220 |
Why?
| | DNA Damage | 1 | 2008 | 437 | 0.220 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2026 | 138 | 0.210 |
Why?
| | Thrombophilia | 1 | 2025 | 89 | 0.210 |
Why?
| | NF-kappa B | 1 | 2008 | 666 | 0.210 |
Why?
| | Spleen | 2 | 2023 | 508 | 0.200 |
Why?
| | Analgesics | 1 | 2026 | 231 | 0.200 |
Why?
| | Intestinal Obstruction | 1 | 2024 | 55 | 0.200 |
Why?
| | Thrombelastography | 1 | 2025 | 192 | 0.200 |
Why?
| | Education, Medical, Graduate | 2 | 2026 | 562 | 0.200 |
Why?
| | Obesity, Morbid | 1 | 2007 | 293 | 0.200 |
Why?
| | Drug Prescriptions | 1 | 2025 | 288 | 0.190 |
Why?
| | Mediastinal Emphysema | 1 | 2023 | 9 | 0.190 |
Why?
| | Esophageal Perforation | 1 | 2023 | 13 | 0.190 |
Why?
| | Antibiotic Prophylaxis | 1 | 2024 | 134 | 0.190 |
Why?
| | Intestine, Small | 1 | 2024 | 167 | 0.190 |
Why?
| | Biological Factors | 1 | 2023 | 39 | 0.190 |
Why?
| | Splenic Artery | 1 | 2022 | 13 | 0.190 |
Why?
| | Hospitals, Pediatric | 2 | 2024 | 558 | 0.190 |
Why?
| | Follow-Up Studies | 4 | 2023 | 5423 | 0.190 |
Why?
| | Morbidity | 2 | 2022 | 322 | 0.190 |
Why?
| | Anesthesiology | 1 | 2025 | 179 | 0.190 |
Why?
| | Lacerations | 1 | 2023 | 40 | 0.180 |
Why?
| | Esophagoplasty | 1 | 2022 | 2 | 0.180 |
Why?
| | Infliximab | 1 | 2023 | 111 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2026 | 303 | 0.180 |
Why?
| | Urban Population | 1 | 2025 | 493 | 0.180 |
Why?
| | Surveys and Questionnaires | 4 | 2026 | 6066 | 0.180 |
Why?
| | Silicones | 1 | 2022 | 31 | 0.180 |
Why?
| | Remission Induction | 1 | 2023 | 307 | 0.180 |
Why?
| | Esophageal Atresia | 1 | 2022 | 32 | 0.180 |
Why?
| | Spectrometry, Fluorescence | 1 | 2022 | 165 | 0.170 |
Why?
| | Aging | 3 | 2008 | 1969 | 0.170 |
Why?
| | Prognosis | 2 | 2021 | 4316 | 0.170 |
Why?
| | Contrast Media | 1 | 2024 | 497 | 0.170 |
Why?
| | Oxidative Stress | 1 | 2008 | 1356 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2024 | 329 | 0.160 |
Why?
| | Radiation Exposure | 1 | 2021 | 63 | 0.160 |
Why?
| | Middle East | 1 | 2020 | 18 | 0.160 |
Why?
| | Myocardial Infarction | 1 | 2008 | 1210 | 0.160 |
Why?
| | Clostridium Infections | 1 | 2021 | 74 | 0.160 |
Why?
| | Time | 1 | 2020 | 84 | 0.160 |
Why?
| | Radiography | 3 | 2019 | 852 | 0.150 |
Why?
| | Developed Countries | 1 | 2019 | 38 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 41 | 0.140 |
Why?
| | Transforming Growth Factor alpha | 2 | 2009 | 55 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2019 | 60 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 295 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2009 | 126 | 0.140 |
Why?
| | Laryngeal Masks | 1 | 2018 | 17 | 0.140 |
Why?
| | Cross Infection | 1 | 2021 | 260 | 0.140 |
Why?
| | Deep Sedation | 1 | 2018 | 16 | 0.140 |
Why?
| | Age Distribution | 1 | 2019 | 403 | 0.140 |
Why?
| | Tomography, X-Ray Computed | 4 | 2026 | 2769 | 0.130 |
Why?
| | Critical Pathways | 1 | 2019 | 109 | 0.130 |
Why?
| | Pylorus | 1 | 2017 | 17 | 0.130 |
Why?
| | Thoracotomy | 1 | 2018 | 85 | 0.130 |
Why?
| | Intestines | 1 | 2021 | 354 | 0.130 |
Why?
| | Electrocoagulation | 1 | 2017 | 35 | 0.130 |
Why?
| | Stents | 1 | 2022 | 564 | 0.130 |
Why?
| | Cervical Vertebrae | 1 | 2019 | 168 | 0.130 |
Why?
| | Fluoroscopy | 1 | 2018 | 180 | 0.130 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 428 | 0.130 |
Why?
| | Umbilicus | 1 | 2017 | 18 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5905 | 0.130 |
Why?
| | Cost Savings | 1 | 2017 | 86 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 639 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2025 | 1149 | 0.120 |
Why?
| | Lipopolysaccharides | 3 | 2009 | 858 | 0.120 |
Why?
| | Delayed Diagnosis | 1 | 2017 | 100 | 0.120 |
Why?
| | Cicatrix | 1 | 2017 | 69 | 0.120 |
Why?
| | Middle Aged | 4 | 2025 | 36215 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2020 | 910 | 0.120 |
Why?
| | Airway Obstruction | 1 | 2017 | 153 | 0.120 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 343 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2023 | 961 | 0.100 |
Why?
| | Liver | 1 | 2023 | 1896 | 0.100 |
Why?
| | Family | 1 | 2018 | 682 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1923 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1508 | 0.100 |
Why?
| | Hospitalization | 1 | 2024 | 2460 | 0.100 |
Why?
| | Surgeons | 1 | 2017 | 340 | 0.090 |
Why?
| | Animals | 11 | 2009 | 38030 | 0.090 |
Why?
| | Risk Factors | 3 | 2024 | 10885 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2019 | 735 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 80 | 0.090 |
Why?
| | Paracrine Communication | 2 | 2008 | 67 | 0.090 |
Why?
| | Animals, Newborn | 3 | 2008 | 891 | 0.080 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2008 | 59 | 0.080 |
Why?
| | Stomach Diseases | 1 | 2010 | 20 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2008 | 4560 | 0.080 |
Why?
| | Jejunum | 1 | 2010 | 37 | 0.080 |
Why?
| | Cytokines | 2 | 2009 | 2067 | 0.080 |
Why?
| | Equipment Failure | 1 | 2011 | 115 | 0.080 |
Why?
| | Hypertension | 2 | 2009 | 1273 | 0.080 |
Why?
| | Stomach | 1 | 2010 | 111 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1193 | 0.080 |
Why?
| | Mice | 6 | 2009 | 18329 | 0.080 |
Why?
| | Receptor Cross-Talk | 1 | 2009 | 21 | 0.070 |
Why?
| | Gastroscopy | 1 | 2009 | 18 | 0.070 |
Why?
| | Laparotomy | 1 | 2009 | 113 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2009 | 4148 | 0.070 |
Why?
| | Propanolamines | 1 | 2009 | 40 | 0.070 |
Why?
| | Pancreatic Elastase | 1 | 2008 | 53 | 0.070 |
Why?
| | Infusions, Intra-Arterial | 1 | 2008 | 61 | 0.070 |
Why?
| | Tumor Necrosis Factors | 1 | 2008 | 10 | 0.070 |
Why?
| | Pressure | 1 | 2009 | 226 | 0.070 |
Why?
| | Orchiectomy | 1 | 2008 | 72 | 0.070 |
Why?
| | Aorta, Abdominal | 1 | 2008 | 52 | 0.070 |
Why?
| | Adult Stem Cells | 1 | 2008 | 40 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 969 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2008 | 51 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2008 | 28 | 0.070 |
Why?
| | Trauma Centers | 2 | 2023 | 466 | 0.070 |
Why?
| | Aged | 2 | 2025 | 26153 | 0.070 |
Why?
| | Comet Assay | 1 | 2008 | 14 | 0.070 |
Why?
| | Young Adult | 3 | 2023 | 14219 | 0.070 |
Why?
| | Electrophoresis | 1 | 2008 | 31 | 0.070 |
Why?
| | Endotoxins | 1 | 2009 | 217 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 7202 | 0.070 |
Why?
| | Rats | 4 | 2008 | 5584 | 0.070 |
Why?
| | Anus, Imperforate | 1 | 2007 | 24 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 527 | 0.070 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2008 | 139 | 0.070 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 192 | 0.070 |
Why?
| | Enema | 1 | 2007 | 46 | 0.070 |
Why?
| | Steroids | 1 | 2008 | 160 | 0.060 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 246 | 0.060 |
Why?
| | Curriculum | 2 | 2025 | 1070 | 0.060 |
Why?
| | Models, Animal | 1 | 2009 | 393 | 0.060 |
Why?
| | Models, Biological | 3 | 2009 | 1764 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 288 | 0.060 |
Why?
| | Probability | 1 | 2008 | 307 | 0.060 |
Why?
| | Random Allocation | 1 | 2008 | 365 | 0.060 |
Why?
| | Gonadal Steroid Hormones | 1 | 2008 | 143 | 0.060 |
Why?
| | Stem Cells | 2 | 2008 | 628 | 0.060 |
Why?
| | Enteral Nutrition | 1 | 2009 | 217 | 0.060 |
Why?
| | Bone Marrow Transplantation | 1 | 2008 | 298 | 0.060 |
Why?
| | Fecal Incontinence | 1 | 2007 | 90 | 0.060 |
Why?
| | Bone Marrow | 1 | 2008 | 306 | 0.060 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 221 | 0.060 |
Why?
| | Reference Values | 1 | 2008 | 798 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 382 | 0.060 |
Why?
| | Administration, Oral | 1 | 2009 | 866 | 0.060 |
Why?
| | Mice, Nude | 1 | 2008 | 679 | 0.060 |
Why?
| | Ventricular Remodeling | 1 | 2008 | 278 | 0.060 |
Why?
| | Ketorolac | 1 | 2026 | 33 | 0.060 |
Why?
| | Incidence | 2 | 2024 | 2923 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 381 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2008 | 5983 | 0.060 |
Why?
| | Reperfusion Injury | 1 | 2008 | 293 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2009 | 3124 | 0.050 |
Why?
| | Kidney Failure, Chronic | 1 | 2011 | 599 | 0.050 |
Why?
| | Testosterone | 1 | 2008 | 416 | 0.050 |
Why?
| | Estradiol | 1 | 2008 | 515 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2024 | 34 | 0.050 |
Why?
| | Cardiac Catheterization | 1 | 2008 | 558 | 0.050 |
Why?
| | Heart | 1 | 2008 | 626 | 0.050 |
Why?
| | Hemodynamics | 1 | 2009 | 1118 | 0.050 |
Why?
| | Myocardium | 1 | 2009 | 934 | 0.050 |
Why?
| | Glucose | 1 | 2009 | 1048 | 0.050 |
Why?
| | Wound Healing | 1 | 2026 | 355 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2121 | 0.050 |
Why?
| | Morals | 1 | 2024 | 78 | 0.050 |
Why?
| | Splenomegaly | 1 | 2022 | 15 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1997 | 0.050 |
Why?
| | Reoperation | 1 | 2026 | 633 | 0.050 |
Why?
| | Play and Playthings | 1 | 2022 | 35 | 0.050 |
Why?
| | Splenectomy | 1 | 2022 | 61 | 0.050 |
Why?
| | Ultrasonography | 1 | 2026 | 785 | 0.040 |
Why?
| | Thrombosis | 1 | 2025 | 400 | 0.040 |
Why?
| | Gestational Age | 1 | 2024 | 987 | 0.040 |
Why?
| | Ligation | 1 | 2020 | 91 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2022 | 202 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 526 | 0.040 |
Why?
| | Prospective Studies | 2 | 2025 | 8057 | 0.040 |
Why?
| | United States | 3 | 2022 | 16098 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2022 | 237 | 0.040 |
Why?
| | Research Design | 1 | 2026 | 1137 | 0.040 |
Why?
| | Eating | 1 | 2022 | 387 | 0.040 |
Why?
| | Communication | 1 | 2025 | 975 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1036 | 0.030 |
Why?
| | Signal Transduction | 2 | 2008 | 5216 | 0.030 |
Why?
| | Computer Simulation | 1 | 2022 | 1003 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2878 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2024 | 946 | 0.030 |
Why?
| | Hypertension, Pulmonary | 1 | 2008 | 1957 | 0.030 |
Why?
| | Transfection | 2 | 2009 | 926 | 0.030 |
Why?
| | RNA, Small Interfering | 2 | 2009 | 637 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 732 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3623 | 0.030 |
Why?
| | Quality of Life | 1 | 2007 | 3204 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1490 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 943 | 0.030 |
Why?
| | Heart Failure | 1 | 2008 | 2326 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2026 | 2381 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1217 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7123 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2019 | 867 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2930 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2008 | 2524 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 6013 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1845 | 0.020 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2010 | 26 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3747 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2008 | 27 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2008 | 52 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 41 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 153 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 309 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 121 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 78 | 0.020 |
Why?
| | Cardiac Output | 1 | 2008 | 179 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 174 | 0.020 |
Why?
| | Osteoblasts | 1 | 2008 | 145 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2008 | 293 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2008 | 216 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 475 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 377 | 0.020 |
Why?
| | Tibia | 1 | 2008 | 176 | 0.020 |
Why?
| | Adipocytes | 1 | 2008 | 223 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1048 | 0.010 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 285 | 0.010 |
Why?
| | Femur | 1 | 2008 | 254 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 317 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 820 | 0.010 |
Why?
| | Tissue Engineering | 1 | 2008 | 439 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1707 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2008 | 364 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 546 | 0.010 |
Why?
| | Fibroblasts | 1 | 2008 | 1025 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 2105 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2008 | 874 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 981 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3342 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2440 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1649 | 0.010 |
Why?
|
|
Novotny's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|